Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 352 participants.
Also called NCT07475949
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 352 participants
- Registry
-
NCT07475949
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07475949. Randomized; single masking; primary purpose treatment. Start 2026-09-24 (actual); primary completion 2028-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging
- Acronym
- UTOPIA
- Condition
- Acute Ischemic Stroke
- Condition
- Tenecteplase
- Intervention (Drug)
- Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
- Intervention (Other)
- Standard medical treatment
- Lead sponsor
- First Affiliated Hospital of Guangxi Medical University
Record details
- Record id
cardio:ct-nct07475949- Content hash
aef56f5b798e0a61d58760d91d0d64b0efc957376479a27e08a7fec298ac6ef7